![]() ReCode Therapeutics ReCode Therapeutics is a company developing non-viral nanoparticles for delivery of diverse RNA- and protein-based therapeutics to targeted tissues, and tRNA NanoCorrectors. | ![]() Chiesi Group Chiesi Group (also known as Chiesi Farmaceutici) is a company that researches, develops, produces, and commercializes therapeutic solutions | ||
Founding Date | Founding Date 1942 | Founding Date 2015 | Founding Date 1935 |
Type | Type Public | Type Private | Type Subsidiary |
Tags | |||
Locations | Locations Trevose, US HQ Philadelphia, US | Locations Menlo Park, US HQ Dallas, US | Locations Parma, IT HQ Melbourne, AU Wien, AT Machelen, BE Santana De Parnaíba, BR São Paulo, BR Sofia, BG see more |
Employees | Employees 81015% decrease | Employees 952% increase | Employees 6,1463% increase |
Twitter followers | Twitter followers N/A | Twitter followers 369 | Twitter followers 1.8 k |
Employee Rating | Employee Rating 2.1 | Employee Rating 5 | Employee Rating 3.9 |
Financial | |||
Revenue (est.) | Revenue (est.) $340.6m (FY, 2022) | Revenue (est.) N/A | Revenue (est.) €2.4b (Y, 2021) |
ReCode Therapeutics is a company developing non-viral nanoparticles for delivery of diverse RNA- and protein-based therapeutics to targeted tissues, and tRNA NanoCorrectors.
View companyChiesi Group (also known as Chiesi Farmaceutici) is a company that researches, develops, produces, and commercializes therapeutic solutions
View company